ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 204 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,359 | +21.7% | 7,790 | +16.7% | 0.00% | – |
| Q2 2023 | $84,128 | -49.2% | 6,677 | -47.4% | 0.00% | – |
| Q1 2023 | $165,520 | +49.2% | 12,684 | +101.6% | 0.00% | – |
| Q4 2022 | $110,969 | +4.7% | 6,291 | -9.7% | 0.00% | – |
| Q3 2022 | $106,000 | +19.1% | 6,969 | +16.3% | 0.00% | – |
| Q2 2022 | $89,000 | -96.8% | 5,993 | -95.2% | 0.00% | – |
| Q1 2022 | $2,820,000 | +140900.0% | 125,266 | +106965.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 117 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | -33.3% | 117 | -16.4% | 0.00% | – |
| Q2 2021 | $3,000 | -80.0% | 140 | -86.1% | 0.00% | – |
| Q1 2021 | $15,000 | 0.0% | 1,008 | 0.0% | 0.00% | – |
| Q4 2020 | $15,000 | +50.0% | 1,008 | -17.0% | 0.00% | – |
| Q3 2020 | $10,000 | +42.9% | 1,214 | +21.4% | 0.00% | – |
| Q2 2020 | $7,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -36.4% | 1,000 | -9.0% | 0.00% | – |
| Q4 2019 | $11,000 | -8.3% | 1,099 | 0.0% | 0.00% | – |
| Q3 2019 | $12,000 | -25.0% | 1,099 | -19.6% | 0.00% | – |
| Q2 2019 | $16,000 | +1500.0% | 1,367 | +1280.8% | 0.00% | – |
| Q1 2019 | $1,000 | -50.0% | 99 | -44.7% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 179 | +19.3% | 0.00% | – |
| Q3 2018 | $2,000 | -99.9% | 150 | -99.9% | 0.00% | – |
| Q2 2016 | $2,394,000 | +0.5% | 188,529 | +4.6% | 0.00% | – |
| Q1 2016 | $2,381,000 | -64.0% | 180,274 | -58.1% | 0.00% | -100.0% |
| Q4 2015 | $6,610,000 | +233.8% | 429,774 | +169.2% | 0.00% | – |
| Q3 2015 | $1,980,000 | -32.1% | 159,651 | -25.1% | 0.00% | – |
| Q2 2015 | $2,914,000 | -81.0% | 213,043 | -83.4% | 0.00% | -100.0% |
| Q1 2015 | $15,376,000 | -19.1% | 1,285,574 | -13.6% | 0.00% | 0.0% |
| Q4 2014 | $18,995,000 | +3.6% | 1,487,489 | +8.8% | 0.00% | 0.0% |
| Q3 2014 | $18,334,000 | -38.6% | 1,366,739 | -26.5% | 0.00% | -50.0% |
| Q2 2014 | $29,859,000 | +58.3% | 1,860,339 | +77.8% | 0.00% | +33.3% |
| Q1 2014 | $18,868,000 | +275.5% | 1,046,500 | +222.0% | 0.00% | +200.0% |
| Q4 2013 | $5,025,000 | +4.0% | 325,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $4,833,000 | -6.6% | 325,000 | -18.8% | 0.00% | 0.0% |
| Q2 2013 | $5,176,000 | – | 400,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |